Representative before the EPO

Company dna ch kilger anwaltspartnerschaft mbb
no operation time available
1 office
active in Legal Services

Siegfried Schreiner has worked on the following 13 EPO patent applications which have been published in the last five years:

EP12007504

Method for the production of multispecific antibodies

IPC classification:
C07K 16/00, C07K 16/28, C07K 16/32
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12007506

Trispecific antibodies against human EGFR, HER2 and HER3

IPC classification:
C07K 16/00, C07K 16/28, C07K 16/32
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12007505

Bispecific antibodies against human EGFR, HER2, and HER3

IPC classification:
C07K 16/00, C07K 16/28, C07K 16/32
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13000570

Method for the selection of antibodies against BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13000571

Bispecific antibodies against CD3epsilon and BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13001840

Bispecific antibodies against CD3e and ROR1

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30, C07K 16/40
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14702616

METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP14705304

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP14179705

Bispecific antibodies against CD3epsilon and BCMA

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION PUBLISHED
EP14715967

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30, C07K 16/40
Agent:
Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP15179545

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
PATENT GRANTED
EP14194151

Bispecific antibodies against CD3epsilon and BCMA

IPC classification:
A61P 35/00, C07K 16/28, C07K 16/46
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION REFUSED
EP14196168

Bispecific antibodies against CD3epsilon and BCMA for use in the treatment of diseases

IPC classification:
A61P 35/00, C07K 16/28, G01N 33/574
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature